Curcumin-Piperine Supplementation in STEMI - SPICE STEMI Trial

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 5, 2025

Primary Completion Date

April 25, 2025

Study Completion Date

May 20, 2025

Conditions
ST Elevation Myocardial Infarction (STEMI)MalondialdehydeHs-CRPCurcuminCurcuma XanthorrhizaHigh-sensitivity C-reactive Protein
Interventions
DIETARY_SUPPLEMENT

Curcumin plus Piperine

A loading dose of 2 capsules (each containing 390 mg curcumin + 20 mg piperine) is administered orally prior to PPCI, followed by maintenance of 1 capsule daily until day 28. Oral administration of standardized curcumin extract (390 mg) combined with piperine (20 mg), given twice daily for 28 days in addition to standard-of-care therapy for STEMI patients undergoing primary percutaneous coronary intervention (PPCI). The curcumin-piperine formulation is used to enhance bioavailability and anti-inflammatory effects, aiming to improve post-MI recovery and reduce oxidative stress.

OTHER

Placebo capsules

A loading dose of 2 capsules (each containing saccarum lactic) is administered orally prior to PPCI, followed by maintenance of 1 capsule daily until day 28. Oral administration of standardized placebo capsule, given twice daily for 28 days in addition to standard-of-care therapy for STEMI patients undergoing primary percutaneous coronary intervention (PPCI).

Trial Locations (1)

50275

Universitas Diponegoro, Semarang

All Listed Sponsors
collaborator

Dr. Kariadi Hospital Semarang, indonesia

UNKNOWN

lead

Universitas Diponegoro

OTHER

NCT07149961 - Curcumin-Piperine Supplementation in STEMI - SPICE STEMI Trial | Biotech Hunter | Biotech Hunter